'It's Not Every Day' This Response Rate Seen in TNBC

A novel targeted therapy provided an incremental improvement in response rate among breast cancer patients with poor prognoses -- those with heavily pretreated metastatic triple-negative breast cancer (TNBC).
Medscape Medical News